JPRN-UMIN000004231Completed未知
A randomized, open-label, crossover, prospective study to investigate utility of a new 24-hour application of transdermal fentanyl patch compared to 72-hour application of transdermal fentanyl patch. - A randomized, open-label, crossover, prospective study to investigate utility of a new 24-hour application of transdermal fentanyl patch compared to 72-hour application of transdermal fentanyl patch.
Department of Pharmacy, Kitasato Institute Hospital0 sites10 target enrollmentStarted: September 21, 2010Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 10
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1.Patient who have hypersensitivity to opioids 2.Patient who have history of opioid abuse 3.Patient who have skin disease (eczema or psoriasis) on the upper arms, flat surface of the upper torso or crural area 4.A body temperature higher than 40 degrees 5.Preganat or nursing patients and patients who may be pregnant 6.After application of fentanyl patch within two days, patient who is treated by opioid receptor antagonists such as pentazocine and buprenorphine or will be treated 7.Surgery in the preceding 7 days or scheduled 8.Patient under 20 years old 9.Patient who have a life expectancy of less than 1 month 10.Patient who judges that the primary physician is inappropriate
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Bacterial adhesion to unworn and worn silicone hydrogel lensesEffect of lens wear on bacterial adhesionEye - Normal eye development and functionACTRN12609000230257Institute for Eye Reseach30
Active, not recruiting
Unknown
A study to characterize nicotine delivery of the JUUL2 electronic nicotine delivery system as compared to a commercially available e-cigarette and combustible cigaretteicotine exposureISRCTN34837836JUUL Labs Inc28
Recruiting
Not Applicable
An open label, prospective, randomized, crossover, monocentric clinical trial to assess safety and performance of a retinal imaging laser eyewear system in patients with visual impairment caused by corneal diseases.H16H17H18S05T26T81T86Corneal scars and opacitiesOther disorders of corneaInjury of eye and orbitBurn and corrosion confined to eye and adnexaComplications of procedures, not elsewhere classifiedFailure and rejection of transplanted organs and tissuesKeratitisDRKS00016583QD Laser Deutschland GmbH21
Completed
Not Applicable
A comparative, open-label, randomised, cross-over phase I trial in healthy volunteers to investigate the relative efficacy, safety and tolerability of OctaplasLG™ versus Octaplas® SDISRCTN35401703Octapharma AG (Switzerland)60
Active, not recruiting
Phase 1
A study in healthy volunteers to compare the test medicine as both a tablet and capsule, to determine the correlation between increases in doses of the test medicine and the amount of test medicine taken up by the body, and to estimate how food affects the test medicine when given as a tabletInflammatory bowel disease (IBD), respiratory diseases including chronic obstructive pulmonary disease (COPD) and severe asthma, and Parkinson’s diseaseISRCTN14438276F. Hoffmann-La Roche Ltd31